Product Description Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, UPC 3 61958 01011 5; NDC 61958-0101-1.

Recall Number D-324-2013

Classification Class I

Code Info Lot #: B120217A, Exp 05/15 - US Distribution

Product Distributed Qty 3,181 vials

Reason For Recall Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).

Event Detail

Event Id 64267

Product Type Drugs

Status Ongoing

Recalling Firm Gilead Sciences, Inc., Foster City, CA, USA


Voluntary / Mandated Voluntary: Firm Initiated

Recall Initiation Date 2013-01-31

Initial Firm Notification of Consignee or Public E-Mail

Distribution Pattern Nationwide in USA, Canada, and UK (Gilead facility in Cork Ireland). Cork facility distributed to Germany/Austria, Italy and Spain.